Quinones are widely distributed in nature, and some quinone compounds are used as therapeutic agents such as anti-cancer, anti-malarial or anti-bacterial drugs. However, their therapeutic use is limited in some cases because the use of most quinones is accompanied by adverse eŠects derived from their cytotoxicity, especially for hepatocytes. Two mechanisms have been proposed to explain quinone toxicity: oxidative stress via redox cycle and the arylation/alkylation of intracellular nucleophiles. A drug metabolizing enzyme, cytochrome P450 is closely involved in the hepatotoxicity of therapeutic agents in general, but quinone hepatotoxicity has been considered not to contribute to cytochrome P450 because the structure of quinone is not modiˆed by cytochrome P450 and thus quinone compounds are thought to be metabolized mainly via a conjugation process. However, we have recently shown that quinone hepatotoxicity is enhanced under conditions of cytochrome P450 inhibition, indicating clearly the involvement of cytochrome P450 in quinone hepatotoxicity. Here, we revisit the generally accepted mechanisms of quinone hepatotoxicity and propose the importance of cytochrome P450 systems in quinone-induced hepatotoxicity on the basis of our recent work.
Quinone cytotoxicity is induced by two principal mechanisms: (i) arylation/alkylation of nucleophiles among important biological constituents, for example, quinones react covalently with thiols, such as GSH or cysteine residues of proteins, to form arylation/alkylation products that eventually cause cellular damage, and (ii) oxidative stress via redox cycling. Redox cycling quinones accept one electron from intracellular reductases to form semiquinone radicals, which are auto-oxidized by donating one electron to molecular oxygen. In this process, massive superoxide anion radicals are produced, leading to oxidative stress. GSH, Reduced glutathione. In the liver, cytochrome P450 accepts an electron from NADPH-cytochrome P450 reductase or NADH-cytochrome b 5 reductase. When redox cycling quinones are used under conditions where cytochrome P450 is operating functionally, NADPH-cytochrome P450 reductase or NADH-cytochrome b 5 reductase supplies electrons to both cytochrome P450 and redox cycling quinones. In other words, quinones compete with cytochrome P450 for electron ‰ow from the reductases. However, under cytochrome P450 inhibition, reductases are not able to transfer an electron to cytochrome P450 and, thus, they donate an electron only to redox cycling quinones, forming semiquinone radicals. As a result, the quinone redox cycle can be potentiated by cytochrome P450 inhibition. 
